The board of directors of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) recommended, on Aug. 5, a 16% cash dividend for the first half of 2024, at SAR 1.6 per share, as shown below:
|
Dividend (H1 2024) |
|
|
Current Capital |
SAR 700 mln |
|
Number of Shares |
70 mln |
|
Total Dividends |
SAR 112 mln |
|
Percentage of Capital |
16% (SAR 1.6 per share) |
|
Record Date |
Aug. 15, 2024 |
|
Payout Date |
Aug. 25, 2024 |
| Announcement | Ex-Dividend | Payment | Dividends (M Riyal) | Dividends * | Notes |
| 06/08/2024 | 15/08/2024 | 25/08/2024 | 112.00 | 1.60 | |
| 04/04/2024 | 04/06/2024 | 13/06/2024 | 105.00 | 1.50 | |
| 10/08/2023 | 20/08/2023 | 03/09/2023 | 70.00 | 1.00 |
| Consolidated cash dividend | Cash dividend per share (SAR) | * The stock price at the beginning of the period (SAR) | Return on the base price |
|---|---|---|---|
| Last 3 Financial years | N/A | N/A | N/A |
| Last 5 Financial years | N/A | N/A | N/A |
| Last 10 Financial years | N/A | N/A | N/A |
| P/E (TTM) | 31.49 |
| P/E Before Unusual Items (TTM) | 31.49 |
| P/BV | 7.62 |
| Dividend Yield | 2.17 % |
| Market Cap. (M) | 11,004.00 |
| Return on Average Assets | 19.87 % |
| Return on Average Equity | 24.90 % |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}